Pharmacological considerations related to smoke-free inpatient environments. | Australas Psychiatry;25(5): 523, 2017 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Pharmacological considerations related to smoke-free inpatient environments.

Alderman, Christopher P.

Australas Psychiatry ; 25(5): 523, 2017 10.

Article in En | MEDLINE | ID: mdl-28992788

Subject(s)

Antipsychotic Agents/metabolism; Caffeine/metabolism; Cytochrome P-450 CYP1A2/metabolism; Hospitalization; Inpatients; Polycyclic Aromatic Hydrocarbons/pharmacology; Smoking Cessation; Smoking/metabolism; Humans

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycyclic Aromatic Hydrocarbons / Antipsychotic Agents / Caffeine / Smoking / Smoking Cessation / Cytochrome P-450 CYP1A2 / Hospitalization / Inpatients Limits: Humans Language: En Journal: Australas Psychiatry Journal subject: PSIQUIATRIA Year: 2017 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycyclic Aromatic Hydrocarbons / Antipsychotic Agents / Caffeine / Smoking / Smoking Cessation / Cytochrome P-450 CYP1A2 / Hospitalization / Inpatients Limits: Humans Language: En Journal: Australas Psychiatry Journal subject: PSIQUIATRIA Year: 2017 Document type: Article